Kluge H - Search Results

1

Risk factors for death during tuberculosis treatment in Orel, Russia.

Dewan PK, Arguin PM, Kiryanova H, Kondroshova NV, Khorosheva TM, Laserson K, Kluge H, Jakubowiak W, Wells C, Kazionny B. Dewan PK, et al. Among authors: kluge h. Int J Tuberc Lung Dis. 2004 May;8(5):598-602. Int J Tuberc Lung Dis. 2004. PMID: 15137537

2

Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation.

Spradling P, Nemtsova E, Aptekar T, Shulgina M, Rybka L, Wells C, Aquino G, Kluge H, Jakubowiak W, Binkin N, Kazeonny B. Spradling P, et al. Among authors: kluge h. Int J Tuberc Lung Dis. 2002 Sep;6(9):757-62. Int J Tuberc Lung Dis. 2002. PMID: 12234130

3

Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.

Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B. Kherosheva T, et al. Among authors: kluge h. Int J Tuberc Lung Dis. 2003 Nov;7(11):1045-51. Int J Tuberc Lung Dis. 2003. PMID: 14598963

4

Implications of the growing HIV-1 epidemic for tuberculosis control in Russia.

Kazionny B, Wells CD, Kluge H, Gusseynova N, Molotilov V. Kazionny B, et al. Among authors: kluge h. Lancet. 2001 Nov 3;358(9292):1513-4. doi: 10.1016/S0140-6736(01)06574-6. Lancet. 2001. PMID: 11705567

5

National anti-tuberculosis drug resistance survey, 2002, in Myanmar.

Ti T, Lwin T, Mar TT, Maung W, Noe P, Htun A, Kluge HH, Wright A, Aziz MA, Paramasivan CN. Ti T, et al. Among authors: kluge hh. Int J Tuberc Lung Dis. 2006 Oct;10(10):1111-6. Int J Tuberc Lung Dis. 2006. PMID: 17044203

6

Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB.

Kimerling ME, Kluge H, Vezhnina N, Iacovazzi T, Demeulenaere T, Portaels F, Matthys F. Kimerling ME, et al. Among authors: kluge h. Int J Tuberc Lung Dis. 1999 May;3(5):451-3. Int J Tuberc Lung Dis. 1999. PMID: 10331736

7

Private GPs contribute to TB control in Myanmar: evaluation of a PPM initiative in Mandalay Division.

Maung M, Kluge H, Aye T, Maung W, Noe P, Zaw M, Jost SP, Uplekar M, Lönnroth K. Maung M, et al. Among authors: kluge h. Int J Tuberc Lung Dis. 2006 Sep;10(9):982-7. Int J Tuberc Lung Dis. 2006. PMID: 16964788

8

The need for longitudinal screening studies in prison TB control.

Kimerling ME, Kluge H. Kimerling ME, et al. Among authors: kluge h. Int J Tuberc Lung Dis. 2005 Jun;9(6):589. Int J Tuberc Lung Dis. 2005. PMID: 15971382 No abstract available.

9

Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection.

Lönnroth K, Aung T, Maung W, Kluge H, Uplekar M. Lönnroth K, et al. Among authors: kluge h. Health Policy Plan. 2007 May;22(3):156-66. doi: 10.1093/heapol/czm007. Epub 2007 Apr 12. Health Policy Plan. 2007. PMID: 17434870

10

Prevention and control of non-communicable diseases in the COVID-19 response.

Kluge HHP, Wickramasinghe K, Rippin HL, Mendes R, Peters DH, Kontsevaya A, Breda J. Kluge HHP, et al. Lancet. 2020 May 30;395(10238):1678-1680. doi: 10.1016/S0140-6736(20)31067-9. Epub 2020 May 10. Lancet. 2020. PMID: 32401713 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters